Test Code HEP.ANTIXA HEPARIN ANTI-XA
Methodology
Chromogenic Assay
Useful For
Heparin Anti-Xa assay is Useful for measuring heparin concentration in patients treated with low-molecular-weight heparin preparations. It is also useful when measuring heparin concentration in the presence of a prolonged baseline APTT (e.g., lupus anticoagulants).
The anti-Xa assay is the preferred method for monitoring low-molecular-weight heparin (LMWH) therapy because of reduced sensitivity of the APTT assay
Specimen Requirements
Specimen Type: Plasma
Container/Tube: Light-blue top (3.2% buffered sodium citrate, with yellow-striped label)
Specimen Volume: Full tube
Collection Instructions:
- Tube must be filled to capacity.
- Ratio of blood to anticoagulant is critical for valid coagulation results.
- Send whole blood in original tube.
- If specimen will arrive at Logan Health Medical Center Laboratory >1 hour after draw, process specimen as follows:
- Spin for 10 minutes at 3,500 rpm (1,500 g).
- Remove plasma from cells and place in a clean, plastic vial.
- Centrifuge again and transfer 1-mL plasma to a clean plastic vial. Leave 0.5 mL plasma in the first aliquot tube to ensure the platelet pellet is not disturbed.
- Freeze specimen.
Moderate or grossly hemolyzed specimens are not acceptable.
Day(s) Test Set Up
Monday through Sunday
Specimen Stability
Refrigerated
Reference Values
UFH Therapeutic Range:
All ages 0.30 - 0.70 IU/mL
LMWH Therapeutic Range:
≥ 18 years 0.50 – 1.0 IU/mL for twice daily dosing
1.0 - 2.0 IU/mL for once daily dosing
≥ 8 weeks to 17 years 0.50 - 1.0 IU/mL
0.10 – 0.30 IU/mL (prophylactic range)
Reference ranges not established for patients less than 8 weeks old.
Performing Laboratory
Logan Health Medical Center Laboratory
Test Classification and CPT Coding
85520